LL-37

What is LL-37?

LL-37 is the body’s own antibiotic. It belongs to a family called antimicrobial peptides, short protein fragments your immune system releases to puncture bacteria, viruses, and fungi on contact. LL-37 is the only one of its specific human subfamily, found in skin, gut, lungs, and immune cells. The injectable or topical versions sold in the peptide world are synthetic copies. It is not an approved drug in the US or, broadly, anywhere as a general therapy; it lives almost entirely in the research lab.

What does LL-37 claim to do?

Marketers pitch LL-37 as a do-everything defender:

• Kills stubborn bacteria, including drug-resistant strains
• Calms chronic infections that won’t clear
• Supports wound healing and the gut lining
• Reduces inflammation tied to “inflammaging,” the low-grade chronic inflammation of aging

Why do people use LL-37?

With antibiotic resistance a real global worry, a natural human molecule that punches holes in bacteria sounds like the future. Longevity enthusiasts add the “inflammaging” angle: if chronic low-level inflammation drives aging, a peptide that tunes immune signaling feels like it could slow the clock. The story is compelling. The evidence is thin.

What does the science actually say about LL-37?

Most of what we know about LL-37 comes from the test tube and from animals. In a dish, it convincingly kills microbes and influences inflammation. In the body, the picture is far messier. LL-37 is a double-edged molecule: depending on dose, location, and context, it can either reduce inflammation or stoke it, and it has been linked to both protective and harmful roles in conditions like psoriasis and certain cancers. That double-edged nature is the central problem, more is not reliably better, and the same peptide can help in one tissue and hurt in another.

Human trials of LL-37 as a therapy are scarce and small. There is no solid human evidence that injecting or applying it slows aging, extends lifespan, or safely resolves chronic infection in otherwise healthy people. The anti-aging case is built almost entirely on mechanism and lab work, a long way from proof.

How do people use LL-37?

There is no established, evidence-based regimen. In experimental and DIY settings it is used by injection or topically, in ranges reported informally rather than from controlled human trials. Because its effects can flip direction depending on context, “informational” is the most this book can responsibly offer. No sourcing or dosing instructions are provided.

Is LL-37 safe? Risks and who should skip it

The honest risk here is unpredictability. A peptide that can amplify inflammation as easily as it dampens it is a poor candidate for casual self-experimentation. People with autoimmune or inflammatory skin conditions (such as psoriasis or rosacea), any cancer history, or who are pregnant or nursing should steer clear. As with all research peptides sold outside pharmacies, purity and sterility are real concerns. Anyone considering it should involve a physician.

The bottom line on LL-37

LL-37 is fascinating biology with almost no human-outcome data and a worrying tendency to cut both ways. For longevity it is speculative at best. This is a research molecule, not a wellness product, and it should be treated as one.